What is Alamar Biosciences, Inc.'s (ALMR) StockRank?

MoatMap's StockRank for Alamar Biosciences, Inc. (ALMR) is 12/100, with a Strong Sell signal. This is a composite score combining Quality (37), Value (24), and Momentum (29) factor ranks across MoatMap's 20,000+ stock universe.

Does Alamar Biosciences, Inc. have an economic moat?

Alamar Biosciences, Inc. (ALMR) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Alamar Biosciences, Inc. a buy, hold, or sell?

MoatMap's current signal for Alamar Biosciences, Inc. (ALMR) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Alamar Biosciences, Inc. in?

Alamar Biosciences, Inc. (ALMR) operates in the Healthcare sector, specifically the Medical Devices industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

ALMR

STRONG SELL

Alamar Biosciences, Inc. · Healthcare · United States · $1.8B · Avg Vol: $9M/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

—

D/E

1.9x

Dividend %

—

COMPANY DESCRIPTION

Alamar Biosciences, Inc. is a life sciences company developing advanced proteomics technologies designed for the early detection and treatment of cancer and inflammatory diseases. The company's proprietary NULISA and Attobody platforms enable ultra-high sensitivity protein detection, overcoming limitations of traditional assays. Its competitive moat is anchored by its cutting-edge molecular detection technology and its potential to revolutionize liquid biopsy and biomarker research.

FINANCIAL SUMMARY (USD)

Year	2024	2025	TTM	2026E	2027E	Fwd CAGR
Revenue	25.1M	74.2M	87.2M	113.2M	162.0M	47.8%
EPS	-0.71	-0.45	-0.65	—	—	—
Shares	66.5M	66.5M	69.3M	—	—	—
Debt	33.1M	41.5M	105.5M	—	—	—
Equity	-133.4M	-159.0M	—	—	—	—
Op CF	-55.2M	-53.6M	-60.9M	—	—	—
Inv CF	-53.9M	46.2M	—	—	—	—
Fin CF	113.4M	10.8M	—	—	—	—

Loading 1Y...

PRICE (1Y)+10.9%

SMA 50SMA 200

$24.40

RSI (14)

46.9

SCORE BREAKDOWN

Quality

ROIC

-24.7%27.5

ROE

—N/A

GP/Assets

35.6%75.4

Op. Margin

-47.4%21.8

FCF/Assets

—N/A

Piotroski

550.0

Int. Cover

-50.0x6.3

D/E Ratio

1.85x6.3

Current Ratio

5.88x75.4

Value

P/E (TTM)

—N/A

EV/EBITDA

-60.3x25.0

P/FCF

—N/A

P/B

-9.3x25.0

P/S

19.0x17.8

Div Yield

—N/A

Momentum

52W High %

—N/A

RS 6M

—N/A

SMA 50/200

—N/A

EPS Rev 4W

0.0%62.6

EPS Rev 12W

—N/A

EPS Improve

-8%18.1

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$1.8B

P/E (Forward)

-34.0x

Gross Margin

57.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ALMR are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
ALMR	Alamar Biosciences, Inc.(you)	$1.8B	12	STRONG SELL
PRCT	PROCEPT BioRobotics Corporation	$950M	14	STRONG SELL
AORT	Artivion, Inc.	$1.2B	22	SELL
TNDM	Tandem Diabetes Care, Inc.	$1.2B	25	SELL
ATEC	Alphatec Holdings, Inc.	$1.3B	27	SELL
BFLY	Butterfly Network, Inc.	$1.7B	36	HOLD
LMRI	Lumexa Imaging Holdings, Inc.	$1.1B	26	SELL
NEOG	Neogen Corporation	$2.0B	37	HOLD
BBNX	Beta Bionics, Inc.	$706M	22	SELL
TMDX	TransMedics Group, Inc.	$2.5B	34	SELL

Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%

Alamar Biosciences, Inc. (ALMR) — Stock Score Summary

Alamar Biosciences, Inc. (ALMR) has a MoatMap StockRank of 12/100 based on Quality (37/100), Value (24/100), and Momentum (29/100) factor scores. The current signal is STRONG SELL.

Key Financial Metrics

Price	$24.40
Market Cap	$1.8B
P/E (Forward)	-33.99
Price/Book	-9.31
Return on Invested Capital	-24.7%
Debt/Equity	1.85x
Gross Margin	57.1%
Operating Margin	-47.4%
Revenue Growth	98.9%

Alamar Biosciences, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Alamar Biosciences, Inc.’s (ALMR) StockRank?: MoatMap’s StockRank for Alamar Biosciences, Inc. (ALMR) is 12/100, with a Strong Sell signal. It is a composite of Quality (37), Value (24), and Momentum (29) factor ranks across MoatMap’s 20,000+ stock universe.
Does Alamar Biosciences, Inc. have an economic moat?: Alamar Biosciences, Inc. (ALMR) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Alamar Biosciences, Inc. a buy, hold, or sell?: MoatMap’s current signal for Alamar Biosciences, Inc. (ALMR) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Alamar Biosciences, Inc. in?: Alamar Biosciences, Inc. (ALMR) operates in the Healthcare sector, specifically the Medical Devices industry (United States).